Haifeng Li, Qixiang Rong, Riqing Huang, Meiting Chen, Qiufan Zheng, Cong Xue, Yanhong Su, Xin An, Yanxia Shi. "Preliminary results of a randomized phase II trial of chidamide plus fulvestrant with or without sintilimab in HR+/HER2- advanced breast cancer after progression on CDK4/6 inhibitors (CISFORT).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e13051